StockTipsArenaBeta

Mankind Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,640+1.40 (+0.05%)
As of 13 Nov 2026

Avg 1-year target

7 of 8 long-term calls BUY

₹2,7975.9% above today's price

Mankind Pharma's average 1-year share price target is ₹2,797, the average of 5 advisors' latest targets. Targets range from ₹2,080 to ₹3,035.

Latest: Nirmal Bang Securities ₹2,995 · 27 Oct 2026

12
11 BUY · 1 SELL, all horizons
5
with an active 1Y target
30%
18 of 60 closed calls hit
75
all horizons, open and closed
Watch MANKIND for new buy/sell callsGet alertsSee 53 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips · page 2 of 2

← Back to filtered view
BUYTarget₹2,460
MKbyMehul Kothari, Anand RathiExpired
1–2 Weeks* · 3 Jun 2026 · entry ₹2,355 · via Zee Business (Live)exit ₹2,359.2
BUYTarget₹2,525
MJbyManas JaiswalExpired
1–2 Weeks* · 29 May 2026 · entry ₹2,375.6 · via CNBC Awaaz.exit ₹2,371.4
BUYTarget₹2,700
CTbyChandan Taparia, Motilal OswalExpired
1–2 Weeks* · 20 May 2026 · entry ₹2,583.9 · via NDTV Profitexit ₹2,372.3
BUYTarget₹2,550
RSbyRajesh SatputeStop-loss hit
BTST · 7 Oct 2026 · entry ₹2,500 · via CNBC Awaaz.exit ₹2,470
BUYTarget₹2,660
MJbyManas JaiswalStop-loss hit
BTST · 28 Jul 2026 · entry ₹2,617.9 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,650
PGbyPrakash GabaStop-loss hit
BTST · 28 Jul 2026 · entry ₹2,615.2 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,600
JTbyJay Thakkar, ICICI SecuritiesStop-loss hit
BTST* · 30 Jun 2026 · entry ₹2,546.4 · via Zee Business (Live)exit ₹2,525
BUYTarget₹2,450
SCbyShrikant Chouhan, Kotak SecuritiesExpired
BTST · 18 Aug 2026 · entry ₹2,380 · via CNBC Awaaz.exit ₹2,390.9
BUYTarget₹2,590
KJbyKavita Jain, Arihant Capital MarketsExpired
BTST* · 30 Jun 2026 · entry ₹2,538 · via CNBC Awaaz.exit ₹2,491.2
BUYTarget₹2,520
RBbyRakesh BansalTarget hit
Intraday · 27 Oct 2026 · entry ₹2,435 · via CNBC Awaaz.exit ₹2,520
BUYTarget₹2,400
PGbyPrakash GabaTarget hit
Intraday · 21 Sept 2026 · entry ₹2,385.5 · via CNBC Awaaz.exit ₹2,400
BUYTarget₹2,375
PGbyPrakash GabaTarget hit
Intraday · 21 Sept 2026 · entry ₹2,338.5 · via CNBC Awaaz.exit ₹2,375
BUYTarget₹2,400
PGbyPrakash GabaTarget hit
Intraday · 18 Jun 2026 · entry ₹2,376 · via CNBC Awaaz.exit ₹2,400
BUYTarget₹2,600
RSbyRajesh SatputeStop-loss hit
Intraday* · 5 Nov 2026 · entry ₹2,560 · via CNBC Awaaz.exit ₹2,520
BUYTarget₹2,460
PGbyPrakash GabaStop-loss hit
Intraday* · 28 Aug 2026 · entry ₹2,419 · via CNBC Awaaz.exit ₹2,400
BUYTarget₹2,450
PGbyPrakash GabaStop-loss hit
Intraday* · 19 Aug 2026 · entry ₹2,412.4 · via CNBC Awaaz.exit ₹2,388
BUYTarget₹2,590
PGbyPrakash GabaStop-loss hit
Intraday* · 1 Jul 2026 · entry ₹2,546 · via CNBC Awaaz.exit ₹2,520
BUYTarget₹2,710
AKbyArun Kumar MantriExpired
Intraday* · 13 Nov 2026 · entry ₹2,647 · via CNBC Awaaz.exit ₹2,639.2
BUYTarget₹2,500
VPbyVaishali Parekh, Prabhudas Lilladher○ No trade
Intraday* · 27 Oct 2026 · entry ₹2,450 · via ET Now
BUYTarget₹2,580
SHbySwati Hotkar, Nirmal Bang SecuritiesExpired
Intraday* · 7 Oct 2026 · entry ₹2,513.7 · via Zee Business (Live)exit ₹2,494.2
BUYTarget₹2,580
NJbyNilesh Jain, Centrum BrokingExpired
Intraday* · 29 Sept 2026 · entry ₹2,530 · via Zee Business (Live)exit ₹2,548.4
BUYTarget₹2,575
RBbyRakesh BansalExpired
Intraday · 25 Sept 2026 · entry ₹2,498 · via CNBC Awaaz.exit ₹2,480.7
BUYTarget₹2,450
RSbyRajesh SatputeExpired
Intraday* · 19 Aug 2026 · entry ₹2,392.1 · via CNBC Awaaz.exit ₹2,390.9
BUYTarget₹2,456
AKbyArun Kumar MantriExpired
Intraday · 18 Jun 2026 · entry ₹2,390 · via CNBC Awaaz.exit ₹2,407.7
BUYTarget₹2,440
DPbyDhvani Patel○ No trade
Intraday · 11 Jun 2026 · entry ₹2,426 · via CNBC Awaaz.

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

Showing 51–75 of 75